Novartis Inclisiran CKJX839A1US02 / VICTORION-INITIATE
Click below to register to attend the Novartis Inclisiran CKJX839A1US02 / VICTORION-INITIATE Virtual Investigator Meeting
October 25, 2021
3:00pm - 6:00pm EDT
( Click Here for Your Time Zone)
Register Here
If you are unable to attend please click the below link
Decline Here
3:00pm - 6:00pm EDT
( Click Here for Your Time Zone)
Register Here
If you are unable to attend please click the below link
Decline Here
Clinical Trial Protocol CKJX839A1US02:A randomized, multicenter, open-label trial comparing the effectiveness of an "inclisiran first" implementation strategy to usual care on LDL cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease and elevated LDL-C (≥70 mg/dL) despite receiving maximally tolerated statin therapy (VICTORION-INITIATE)